TY - JOUR AU - Clayman, G. L. PY - 2000 DA - 2000// TI - The current status of gene therapy JO - Semin Oncol VL - 27 ID - Clayman2000 ER - TY - JOUR AU - Gibson, S. A. AU - Pellenz, C. AU - Hutchison, R. E. AU - Davey, F. AU - Shillitoe, E. J. PY - 2000 DA - 2000// TI - Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector JO - Clin Cancer Res VL - 6 ID - Gibson2000 ER - TY - JOUR AU - Shillitoe, E. J. PY - 2006 DA - 2006// TI - Papillomaviruses as targets for cancer gene therapy JO - Cancer Gene Ther VL - 13 UR - https://doi.org/10.1038/sj.cgt.7700926 DO - 10.1038/sj.cgt.7700926 ID - Shillitoe2006 ER - TY - JOUR AU - He, Y. AU - Zeng, Q. AU - Drenning, S. D. AU - Melhem, M. F. AU - Tweardy, D. J. AU - Huang, L. PY - 1998 DA - 1998// TI - Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter JO - J Natl Cancer Inst VL - 90 UR - https://doi.org/10.1093/jnci/90.14.1080 DO - 10.1093/jnci/90.14.1080 ID - He1998 ER - TY - JOUR AU - Xi, S. AU - Grandis, J. R. PY - 2003 DA - 2003// TI - Gene therapy for the treatment of oral squamous cell carcinoma JO - J Dent Res VL - 82 UR - https://doi.org/10.1177/154405910308200104 DO - 10.1177/154405910308200104 ID - Xi2003 ER - TY - JOUR AU - Shillitoe, E. J. AU - Hermonat, P. L. AU - Noonan, S. AU - Shi, B. PY - 2001 DA - 2001// TI - Effectiveness of different promoters in adeno-associated virus vectors for expression of genes in oral cancer cells JO - Int J Oral Biol VL - 26 ID - Shillitoe2001 ER - TY - JOUR AU - Tyminski, E. AU - Leroy, S. AU - Terada, K. AU - Finkelstein, D. M. AU - Hyatt, J. L. AU - Danks, M. K. PY - 2005 DA - 2005// TI - Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0154 DO - 10.1158/0008-5472.CAN-05-0154 ID - Tyminski2005 ER - TY - JOUR AU - Omalley, B. W. AU - Cope, K. A. AU - Chen, S. H. AU - Li, D. AU - Schwarta, M. R. AU - Woo, S. L. PY - 1996 DA - 1996// TI - Combination gene therapy for oral cancer in a murine model JO - Cancer Res VL - 56 ID - Omalley1996 ER - TY - JOUR AU - Clayman, G. L. AU - Trapnell, B. C. AU - Mittereder, N. AU - Liu, T. J. AU - Eicher, S. AU - Zhang, S. PY - 1995 DA - 1995// TI - Transduction of normal and malignant oral epithelium by an adenovirus vector: the effect of dose and treatment time on transduction efficiency and tissue penetration JO - Cancer Gene Ther VL - 2 ID - Clayman1995 ER - TY - JOUR AU - Sauthoff, H. AU - Hu, J. AU - Maca, C. AU - Goldman, M. AU - Heitner, S. AU - Yee, H. PY - 2003 DA - 2003// TI - Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points JO - Human Gene Ther VL - 14 UR - https://doi.org/10.1089/104303403321467199 DO - 10.1089/104303403321467199 ID - Sauthoff2003 ER - TY - JOUR AU - Mineta, T. AU - Rabkin, S. D. AU - Yazaki, T. AU - Hunter, W. D. AU - Martuza, R. L. PY - 1995 DA - 1995// TI - Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas JO - Nature Med VL - 1 UR - https://doi.org/10.1038/nm0995-938 DO - 10.1038/nm0995-938 ID - Mineta1995 ER - TY - JOUR AU - Bennett, J. AU - Delman, K. AU - Burt, B. AU - Mariotti, A. AU - Malhotra, S. AU - Zager, J. PY - 2002 DA - 2002// TI - Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer JO - Cancer Gene Ther VL - 9 UR - https://doi.org/10.1038/sj.cgt.7700510 DO - 10.1038/sj.cgt.7700510 ID - Bennett2002 ER - TY - JOUR AU - Meignier, B. AU - Martin, B. AU - Whitley, R. AU - Roizman, B. PY - 1990 DA - 1990// TI - In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus) JO - J Infect Dis VL - 162 UR - https://doi.org/10.1093/infdis/162.2.313 DO - 10.1093/infdis/162.2.313 ID - Meignier1990 ER - TY - JOUR AU - Wong, R. J. AU - Patel, S. G. AU - Kim, S. H. AU - DeMatteo, R. P. AU - Malhotra, S. AU - Bennett, J. J. PY - 2001 DA - 2001// TI - Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma JO - Hum Gene Ther VL - 12 UR - https://doi.org/10.1089/10430340150218396 DO - 10.1089/10430340150218396 ID - Wong2001 ER - TY - JOUR AU - Carew, J. F. AU - Kooby, D. A. AU - Halterman, M. W. AU - Federoff, H. J. AU - Fong, Y. PY - 1999 DA - 1999// TI - Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus Type-1 (G207) JO - Hum Gene Ther VL - 10 UR - https://doi.org/10.1089/10430349950017608 DO - 10.1089/10430349950017608 ID - Carew1999 ER - TY - JOUR AU - Kirn, D. PY - 2001 DA - 2001// TI - Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer; what have we learned? JO - Gene Ther VL - 8 UR - https://doi.org/10.1038/sj.gt.3301377 DO - 10.1038/sj.gt.3301377 ID - Kirn2001 ER - TY - JOUR AU - Crompton, A. M. AU - Kirn, D. H. PY - 2007 DA - 2007// TI - From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development JO - Curr Cancer Drug Targets VL - 7 UR - https://doi.org/10.2174/156800907780058862 DO - 10.2174/156800907780058862 ID - Crompton2007 ER - TY - JOUR AU - Miyatake, S. AU - Iyer, A. AU - Martuza, R. L. AU - Rabkin, S. D. PY - 1997 DA - 1997// TI - Transcriptional targeting of herpes simplex virus for cell-specific replication JO - J Virol VL - 71 ID - Miyatake1997 ER - TY - JOUR AU - Yamamura, H. AU - Hashio, M. AU - Noguchi, M. AU - Sugenoya, Y. AU - Asakada, M. AU - Hirano, N. PY - 2001 DA - 2001// TI - Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors JO - Cancer Res VL - 61 ID - Yamamura2001 ER - TY - JOUR AU - Chung, R. Y. AU - Saeki, Y. AU - Chiocca, E. A. PY - 1999 DA - 1999// TI - B-myb promoter retargeting of herpes simplex virus gamma-34.5 gene-mediated virulence toward tumor and cycling cells JO - J Virol VL - 73 ID - Chung1999 ER - TY - JOUR AU - Kasuya, H. AU - Pawlik, T. AU - Mullen, J. AU - Donahue, J. AU - Nakamura, H. AU - Chandrasekhar, S. PY - 2004 DA - 2004// TI - Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-3431 DO - 10.1158/0008-5472.CAN-03-3431 ID - Kasuya2004 ER - TY - JOUR AU - Shillitoe, E. J. AU - Noonan, S. PY - 2000 DA - 2000// TI - Strength and specificity of different gene promoters in oral cancer cells JO - Oral Oncol VL - 36 UR - https://doi.org/10.1016/S1368-8375(99)00064-0 DO - 10.1016/S1368-8375(99)00064-0 ID - Shillitoe2000 ER - TY - JOUR AU - Griffith, C. AU - Noonan, S. AU - Lou, E. AU - Shillitoe, E. J. PY - 2007 DA - 2007// TI - An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16 JO - Cancer Gene Ther VL - 14 UR - https://doi.org/10.1038/sj.cgt.7701089 DO - 10.1038/sj.cgt.7701089 ID - Griffith2007 ER - TY - JOUR AU - Teichler Zallen, D. PY - 2000 DA - 2000// TI - US gene therapy in crisis JO - Trends Genet VL - 16 UR - https://doi.org/10.1016/S0168-9525(00)02025-4 DO - 10.1016/S0168-9525(00)02025-4 ID - Teichler Zallen2000 ER - TY - JOUR AU - Hacein-Bey-Abina, S. AU - Garrigue, A. AU - Wang, G. P. AU - Soulier, J. AU - Lim, A. AU - Morillon, E. PY - 2008 DA - 2008// TI - Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 JO - J Clin Invest VL - 118 UR - https://doi.org/10.1172/JCI35700 DO - 10.1172/JCI35700 ID - Hacein-Bey-Abina2008 ER - TY - JOUR AU - Toda, M. AU - Martuza, R. L. AU - Rabkin, S. D. PY - 2000 DA - 2000// TI - Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor JO - Mol Ther VL - 2 UR - https://doi.org/10.1006/mthe.2000.0130 DO - 10.1006/mthe.2000.0130 ID - Toda2000 ER - TY - JOUR AU - Israyelyan, A. H. AU - Melancon, J. M. AU - Lomax, L. G. AU - Sehgal, I. AU - Lauschner, C. AU - Kearney, M. T. PY - 2007 DA - 2007// TI - Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells JO - Hum Gene Ther VL - 18 UR - https://doi.org/10.1089/hum.2006.145 DO - 10.1089/hum.2006.145 ID - Israyelyan2007 ER - TY - JOUR AU - Ikeda, K. AU - Ichikawa, T. AU - Wakimoto, H. AU - Silver, J. S. AU - Deisboeck, T. S. AU - Finkelstein, D. PY - 1999 DA - 1999// TI - Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses JO - Nature Med VL - 5 UR - https://doi.org/10.1038/11320 DO - 10.1038/11320 ID - Ikeda1999 ER - TY - JOUR AU - Ikeda, K. AU - Wakimoto, H. AU - Ichikawa, T. AU - Jhung, S. AU - Hochberg, F. H. AU - Louis, D. N. PY - 2000 DA - 2000// TI - Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant JO - J Virol VL - 74 UR - https://doi.org/10.1128/JVI.74.10.4765-4775.2000 DO - 10.1128/JVI.74.10.4765-4775.2000 ID - Ikeda2000 ER - TY - JOUR AU - Fulci, G. AU - Breymann, L. AU - Gianni, D. AU - Kurozomi, K. AU - Rhee, S. S. AU - Yu, J. PY - 2006 DA - 2006// TI - Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses JO - PNAS (USA) VL - 103 UR - https://doi.org/10.1073/pnas.0605496103 DO - 10.1073/pnas.0605496103 ID - Fulci2006 ER - TY - JOUR AU - Miller, C. G. AU - Fraser, N. W. PY - 2000 DA - 2000// TI - Role of the immune response during neuro-attenuated herpes simplex virus-mediated tumor destruction in a murine intracranial melanoma model JO - Cancer Res VL - 60 ID - Miller2000 ER - TY - JOUR AU - Shillitoe, E. J. AU - Pellenz, C. PY - 2005 DA - 2005// TI - Factors that limit the effectiveness of herpes simplex virus type 1 for treatment of oral cancer in mice JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2302 DO - 10.1158/1078-0432.CCR-04-2302 ID - Shillitoe2005 ER - TY - JOUR AU - Kuriyama, N. AU - Kuriyama, H. AU - Julin, C. M. AU - Lamborn, K. R. AU - Israel, M. A. PY - 2001 DA - 2001// TI - Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model JO - Cancer Res VL - 61 ID - Kuriyama2001 ER - TY - JOUR AU - Ganesh, S. AU - Gonzalez-Edick, M. AU - Gibbons, D. AU - Van Roey, M. AU - Joos, K. PY - 2008 DA - 2008// TI - Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4732 DO - 10.1158/1078-0432.CCR-07-4732 ID - Ganesh2008 ER - TY - JOUR AU - McKee, T. D. AU - Grandi, P. AU - Mok, W. AU - Alexandrakis, G. AU - Insin, N. AU - Zimmer, J. P. PY - 2006 DA - 2006// TI - Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-2242 DO - 10.1158/0008-5472.CAN-05-2242 ID - McKee2006 ER - TY - JOUR AU - Ganesh, S. AU - Gonzalez Edick, M. AU - Idamakanti, N. AU - Abramova, M. AU - Vanroey, M. AU - Robinson, M. PY - 2007 DA - 2007// TI - Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-4260 DO - 10.1158/0008-5472.CAN-06-4260 ID - Ganesh2007 ER - TY - JOUR AU - Nagano, S. AU - Perentes, J. Y. AU - Jain, R. K. AU - Boucher, Y. PY - 2008 DA - 2008// TI - Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6193 DO - 10.1158/0008-5472.CAN-07-6193 ID - Nagano2008 ER - TY - JOUR AU - Chahlavi, A. AU - Todo, T. AU - Martuza, R. L. AU - Rabkin, S. D. PY - 1999 DA - 1999// TI - Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma JO - Neoplasia VL - 1 UR - https://doi.org/10.1038/sj.neo.7900016 DO - 10.1038/sj.neo.7900016 ID - Chahlavi1999 ER - TY - JOUR AU - Cinatl, J. AU - Cinatl, J. AU - Michaelis, M. AU - Kabickova, H. AU - Kotchetkav, R. AU - Vogel, J. U. PY - 2003 DA - 2003// TI - Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma JO - Cancer Res VL - 63 ID - Cinatl2003 ER - TY - JOUR AU - Eisenberg, D. P. AU - Adsumilli, P. S. AU - Hendershott, K. J. AU - Yu, Z. AU - Mullerad, M. AU - Chan, M. K. PY - 2005 DA - 2005// TI - 5-Fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer JO - J Gastrointest Surg VL - 9 UR - https://doi.org/10.1016/j.gassur.2005.06.024 DO - 10.1016/j.gassur.2005.06.024 ID - Eisenberg2005 ER - TY - CHAP AU - Katsura, T. AU - Iwai, S. AU - Ota, Y. AU - Shimizu, H. AU - Ikuta, K. AU - Yura, Y. PY - 2008 DA - 2008// TI - The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells BT - Cancer Gene Ther ID - Katsura2008 ER - TY - JOUR AU - Lou, E. AU - Kellman, R. M. AU - Shillitoe, E. J. PY - 2002 DA - 2002// TI - Effect of herpes simplex virus type-1 on growth of oral cancer in an immunocompetent, orthotopic mouse model JO - Oral Oncol VL - 38 UR - https://doi.org/10.1016/S1368-8375(01)00069-0 DO - 10.1016/S1368-8375(01)00069-0 ID - Lou2002 ER - TY - JOUR AU - Naito, S. AU - Obayashi, S. AU - Sumi, T. AU - Iwai, S. AU - Nakazawa, M. AU - Ikuta, K. PY - 2006 DA - 2006// TI - Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide JO - Cancer Gene Ther VL - 13 UR - https://doi.org/10.1038/sj.cgt.7700957 DO - 10.1038/sj.cgt.7700957 ID - Naito2006 ER - TY - JOUR AU - Stanziale, S. F. AU - Petrowsky, H. AU - Adusumilli, P. S. AU - Ben-Porat, L. AU - Gonen, M. AU - Fong, Y. PY - 2004 DA - 2004// TI - Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-1083-3 DO - 10.1158/1078-0432.CCR-1083-3 ID - Stanziale2004 ER - TY - JOUR AU - Stiles, B. M. AU - Adusumilli, P. S. AU - Stanziale, S. F. AU - Eisenberg, D. P. AU - Bhargava, A. AU - Kim, T. H. PY - 2006 DA - 2006// TI - Estrogen enhances efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor positive breast cancer JO - Int J Oncol VL - 28 ID - Stiles2006 ER - TY - JOUR AU - Bennett, J. J. AU - Adsumilli, P. AU - Petrowsky, H. AU - Burt, B. M. AU - Roberts, G. AU - Delman, K. A. PY - 2004 DA - 2004// TI - Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207) JO - FASEB J VL - 18 ID - Bennett2004 ER - TY - CHAP AU - Ganesh, S. AU - Gonzalez-Edick, M. AU - Gibbons, D. AU - Ge, Y. AU - Vanroey, M. AU - Robinson, M. PY - 2008 DA - 2008// TI - Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer BT - Cancer Gene Ther ID - Ganesh2008 ER - TY - JOUR AU - Khuri, F. R. AU - Nemunaitis, J. AU - Ganly, I. AU - Arseneau, J. AU - Tannock, I. F. AU - Romel, L. PY - 2000 DA - 2000// TI - A controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer JO - Nature Med VL - 6 UR - https://doi.org/10.1038/78638 DO - 10.1038/78638 ID - Khuri2000 ER - TY - JOUR AU - Aghi, M. AU - Rabkin, S. AU - Martuza, R. L. PY - 2006 DA - 2006// TI - Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication JO - J Natl Cancer Inst VL - 98 UR - https://doi.org/10.1093/jnci/djj003 DO - 10.1093/jnci/djj003 ID - Aghi2006 ER -